Cargando…
Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation
Mammalian cells typically start the cell-cycle entry program by activating cyclin-dependent protein kinase 4/6 (CDK4/6). CDK4/6 activity is clinically relevant as mutations, deletions, and amplifications that increase CDK4/6 activity contribute to the progression of many cancers. However, when CDK4/...
Autores principales: | Yang, Hee Won, Cappell, Steven D, Jaimovich, Ariel, Liu, Chad, Chung, Mingyu, Daigh, Leighton H, Pack, Lindsey R, Fan, Yilin, Regot, Sergi, Covert, Markus, Meyer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213986/ https://www.ncbi.nlm.nih.gov/pubmed/32255427 http://dx.doi.org/10.7554/eLife.44571 |
Ejemplares similares
-
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
por: Pack, Lindsey R., et al.
Publicado: (2021) -
Molecular control of cell density-mediated exit to quiescence
por: Fan, Yilin, et al.
Publicado: (2021) -
Stochastic Endogenous Replication Stress Causes ATR-Triggered Fluctuations in CDK2 Activity that Dynamically Adjust Global DNA Synthesis Rates
por: Daigh, Leighton H., et al.
Publicado: (2018) -
Altered G1 signaling order and commitment point in cells proliferating without CDK4/6 activity
por: Liu, Chad, et al.
Publicado: (2020) -
Sterol Metabolism Differentially Contributes to Maintenance and Exit of Quiescence
por: Peselj, Carlotta, et al.
Publicado: (2022)